go back

Ciltacabtagene Autoleucel (Carvykti) CAR-T Therapy

Hawaii rates for HCPCS Q2056

Ciltacabtagene autoleucel, up to 100 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

How much does Carvykti (ciltacabtagene autoleucel) cost?

$562,341

Typical physician fee. In Hawaii, July 2026.

Insurers have agreed to pay about $562,341 for this service. Most negotiated rates run $562,341 to $562,341.

These are rates insurers have negotiated with providers, not the amount a patient is billed. What you owe depends on your plan's deductible and coinsurance. Based on rates published by 3 insurance carriers under federal price transparency rules.

How much rates vary

Professionalmedian $562,341 · 10th to 90th $562,341 to $676,083
$1Mprofessional $562,341

Distribution of negotiated rates across all payers (price axis is log-scale). Each curve is scaled to its own total: facility and professional rates are different services, shown together to compare where they cluster. Need provider-level prices or 24+ months of history? Contact us.

Rates by insurance carrier

Insurance Carrier
Cigna
Setting
Professional
Modifier
Global
Typical Low
$660,693.45
Median
$660,693.45
Typical High
$660,693.45
HMSA
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$562,341.33
Kaiser Permanente
Setting
Professional
Modifier
Global
Typical Low
$645,654.23
Median
$707,945.78
Typical High
$1,148,153.62

Where Hawaii sits

The same service costs 45.7 times more in Delaware than in Oklahoma. Every bar is a state, most expensive first. Touch or drag across it to read any state, then open that state for its carriers and full range.

Hawaii· 48th of 51

$562,341

DE $1,995,262OK $43,652

Median negotiated rate in each state, from every insurer that publishes one. States where no insurer publishes a rate for this service are not shown.